Panchsheel Organics Limited Stock

Equities

PANCHSHEEL

INE316G01019

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:55 2024-04-26 am EDT 5-day change 1st Jan Change
203.8 INR -0.44% Intraday chart for Panchsheel Organics Limited +0.72% +3.95%
Sales 2022 690M 8.28M Sales 2023 1.03B 12.38M Capitalization 2.04B 24.45M
Net income 2022 83M 996K Net income 2023 141M 1.69M EV / Sales 2022 2.26 x
Net Debt 2022 21.41M 257K Net Debt 2023 21.15M 254K EV / Sales 2023 2 x
P/E ratio 2022
18.4 x
P/E ratio 2023
14.5 x
Employees 180
Yield 2022
0.98%
Yield 2023
1.96%
Free-Float 36.79%
More Fundamentals * Assessed data
Dynamic Chart
Panchsheel Organics Limited Announces Resignation of Hitesh Singh Parihar as Company Secretary & Compliance Officer CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 13, 2024 CI
Panchsheel Organics Names CFO MT
Panchsheel Organics Limited Announces CFO Changes CI
Panchsheel Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Panchscheel Organics Board Declares Interim Dividend for Fiscal 2024 MT
Panchsheel Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year Ending on March 31, 2023, Payable on or Before December 10, 2023 CI
Panchsheel Organics Limited Approves Dividend CI
Panchsheel Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Panchsheel Organics Limited Recommends Final Dividend for the Financial Year 2022-23 CI
Panchsheel Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Panchsheel Organics Limited Announces the Appointment of Hitesh Singh Parihar as Company Secretary and Compliance Officer CI
Panchsheel Organics Limited Announces the Appointment of Gaurang Natavar Patel as Chief Financial Officer CI
Panchsheel Organics Limited Announces Demise of Chandrakant Shah, Chief Financial Officer CI
More news
1 day-0.44%
1 week+0.72%
Current month+4.41%
1 month+0.87%
3 months+5.52%
6 months+13.07%
Current year+3.95%
More quotes
1 week
198.50
Extreme 198.5
207.30
1 month
192.40
Extreme 192.4
208.70
Current year
173.00
Extreme 173
226.50
1 year
160.00
Extreme 160
226.50
3 years
42.30
Extreme 42.3
425.55
5 years
17.10
Extreme 17.1
425.55
10 years
10.25
Extreme 10.25
425.55
More quotes
Managers TitleAgeSince
Chief Executive Officer 78 09-08-30
Director/Board Member 66 10-11-14
Members of the board TitleAgeSince
Chief Executive Officer 78 09-08-30
Director/Board Member 69 10-11-14
Director/Board Member 66 10-11-14
More insiders
Date Price Change Volume
24-04-26 203.8 -0.44% 7,180
24-04-25 204.6 +2.04% 20,275
24-04-24 200.6 -1.35% 26,064
24-04-23 203.3 +0.52% 12,136
24-04-22 202.2 -0.02% 15,937

Delayed Quote Bombay S.E., April 26, 2024 at 06:00 am EDT

More quotes
Panchsheel Organics Limited is an India-based company engaged in manufacturing and exporting active pharmaceutical ingredients (APIs), intermediates and finished formulations (both human and veterinary). Its specialties include steroids and hormones, veterinary products, over-the-counter products, oncology products, nutraceutical products, micro pellets and direct compression granules, fitness and healthcare, and product development and testing laboratory. The Company offers a range of products under categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis and erectile dysfunction, among others. Its API product range includes Acamprosate Calcium, Amiodarone, Leflunomide, and others. Its hormones and steroids product range includes Cyproterone Acetate, Desogestrel and others. Its nutraceuticals and healthcare products include Alpha Linolenic Acid (ALA) Powder, Phytosterol, and others.
More about the company
  1. Stock Market
  2. Equities
  3. PANCHSHEEL Stock